植入前遗传学检测并非X染色体异常患者的首选推荐
该回顾性队列研究纳入394例X染色体异常女性,比较常规IVF/ICSI与PGT的妊娠结局。结果显示两组活产率、临床妊娠率及流产率均无显著差异,且胚胎X染色体异常频率低于常染色体。因此,无其他PGT指征时,PGT不应作为X染色体异常患者的首选推荐。
要点
- X染色体异常女性中,PGT与常规IVF/ICSI的活产率、临床妊娠率及流产率无显著差异。
- 胚胎染色体异常更常见于常染色体22、21、16,X染色体异常频率仅8.73%。
- 无其他PGT指征时,不推荐X染色体异常患者首选PGT。
核心结论
- 在无其他PGT指征的情况下,PGT不是X染色体异常女性的首选推荐。
研究设计与样本
- 回顾性队列研究,纳入2011年6月至2019年8月在山东大学附属生殖医院首次取卵并首次胚胎移植的394例X染色体异常女性。
- 常规IVF/ICSI组284例,PGT组110例,比较首次新鲜或冷冻胚胎移植周期的妊娠结局。
主要发现
- PGT组与IVF/ICSI组首次新鲜或冷冻移植的活产率相似:PGT-FISH 39.13% vs IVF/ICSI 42.58%(Padj=0.558);PGT-FISH 66.67% vs PGT-aCGH/NGS 52.08% vs IVF/ICSI 53.06%(Padj=0.756)。
- 临床妊娠率相似:PGT-FISH 60.87% vs IVF/ICSI 50.97%(Padj=0.672);PGT-FISH 88.89% vs PGT-aCGH/NGS 58.33% vs IVF/ICSI 69.39%(Padj=0.480)。
- 流产率相似:PGT-FISH 35.71% vs IVF/ICSI 16.46%(Padj=0.136);PGT-FISH 12.50% vs PGT-aCGH/NGS 10.71% vs IVF/ICSI 23.53%(Padj=0.352)。
- 母儿并发症率在新鲜和冷冻移植中PGT组与IVF/ICSI组相当(10.00% vs 8.85%,P=1.000;21.74% vs 14.55%,P=0.272)。
- 胚胎染色体异常分布更常见于常染色体22(20.39%)、21(18.45%)和16(17.47%),X染色体为8.73%。
临床怎么用
- 对于X染色体异常女性,在缺乏其他PGT指征时,可优先考虑常规IVF/ICSI而非PGT。
- 遗传和生殖咨询时应告知患者PGT并未显著改善其妊娠结局。
局限性
- 回顾性研究存在选择偏倚。
- 参与者中4.84%为X染色体嵌合体,缺乏典型Turner综合征躯体异常。
- PGT组复发性流产史和异常后代史发生率高于IVF/ICSI组,尽管进行了二元logistic回归分析。
- FISH仅使用X/Y探针,缺乏常染色体参照,可能导致误诊和偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Should women with X chromosome abnormalities (XCAs) be recommended to have embryos selected by both morphological and cytogenetic assessment through preimplantation genetic testing (PGT) rather than morphological assessment only in conventional IVF/ICSI treatment? SUMMARY ANSWER: PGT is not a preferred recommendation for women with XCAs in the absence of other PGT indications. WHAT IS KNOWN ALREADY: XCAs are the most frequent sort of chromosomal aberrations in infertile women. Patients with a complete or partial absence of one X chromosome, diagnosed as Turner Syndrome (TS), demonstrate low spontaneous pregnancy rates (5-7%) and high miscarriage rates (22.8-30.8%), as well as high chances of birth defects (20%). PGT is known to improve pregnancy rates and decrease the incidence of miscarriage in couples with chromosomal aberrations such as Robertsonian and reciprocal translocations and Klinefelter Syndrome. STUDY DESIGN, SIZE, DURATION: A retrospective cohort study was conducted with 394 women with XCAs and undergoing their first oocyte retrieval and first embryo transfer cycle from June 2011 to August 2019 in the Reproductive Hospital Affiliated to Shandong University. PARTICIPANTS/MATERIALS, SETTING, METHODS: Pregnancy outcomes were compared between the conventional IVF/ICSI group (n = 284) and the PGT group (n = 110) in the first fresh or frozen embryo transfer cycle for each woman with XCAs. Three platforms were applied in PGT: fluorescence in situ hybridisation (FISH, n = 34), array comparative genomic hybridisation (aCGH, n = 24) and next-generation sequencing (NGS, n = 51). The embryo aneuploidy rate and distribution of embryonic chromosomal aberrations revealed by aCGH or NGS were analysed and stratified by maternal age and type of XCAs to assess the effect of maternal XCAs on embryo karyotypes. MAIN RESULT AND THE ROLE OF CHANCE: The live birth rate (LBR) per embryo transfer was similar between the PGT group and IVF/ICSI group both in the first cycle of fresh or frozen embryo transfer respectively (39.13% in PGTFISH vs 42.58% in IVF/ICSI, Padj=0.558; 66.67% in PGTFISH vs 52.08% in PGTaCGH/NGS vs 53.06% in IVF/ICSI, Padj=0.756), as was the clinical pregnancy rate (60.87% in PGTFISH vs 50.97% in IVF/ICSI, Padj =0.672; 88.89% in PGTFISH vs 58.33% in PGTaCGH/NGS vs 69.39% in IVF/ICSI, Padj =0.480) and the pregnancy loss rate (35.71% in PGTFISH vs 16.46% in IVF/ICSI, Padj =0.136; 12.50% in PGTFISH vs 10.71% in PGTaCGH/NGS vs 23.53% in IVF/ICSI, Padj =0.352). The rates of maternal and neonatal complications were also comparable between the PGT and IVF/ICSI groups with fresh and frozen transfers respectively (10.00% vs 8.85%, P = 1.000; 21.74% vs 14.55%, P = 0.272). Intriguingly, the distribution of embryonic chromosome abnormalities was more frequent on autosomes 22 (20.39%), 21 (18.45%) and 16 (17.47%), compared with the X chromosome (8.73%). LIMITATIONS, REASONS FOR CAUTION: Selection bias is an inherent drawback of a retrospective study. First, our participants hosted 4.84% X chromosome mosaicism with few typical somatic anomalies of TS. Second, the incidences of history of recurrent miscarriage and abnormal offspring in the PGT group were higher than in IVF/ICSI group although binary logistic regression analysis was performed to attenuate the modifying effect of confounding factors. Third, FISH performed in this study only used X/Y probes and lacked the reference of autosome, which might have resulted in misdiagnosis and bias. Finally, intrinsic disadvantages could not be totally avoided due to the retrospective nature of this study. WIDER IMPLICATION OF THE FINDINGS: In the current study, comparable pregnancy outcomes were revealed among a large cohort of women with XCAs undergoing their first cycles of PGT or conventional IVF/ICSI treatment. Moreover, the X chromosome abnormality was illustrated to cause no higher frequency of aberrations in embryos. Our data provided perspectives for genetic and reproductive counselling to XCAs individuals and their families. STUDY FUNDING/COMPETING INTEREST(S): This work was supported by National Research and Development Plan (2016YFC1000604 and 2017YFC1001100), the National Natural Science Foundation of China (81701406), Shandong Science Fund for Distinguished Young Scholars (JQ201720), Taishan Scholars Program for Young Experts of Shandong Province (tsqn20161069) and Projects of Medical and Health Technology Development Program in Shandong Province (202005010520, 202005010523 and 2016WS0368). There is no conflict of interest to declare. TRIAL REGISTRATION NUMBER: N/A.
引用
- Li C, Dang Y, Li J, et al. Preimplantation genetic testing is not a preferred recommendation for patients with X chromosome abnormalities. Hum Reprod. 2021. PMID: 34323971. doi:10.1093/humrep/deab177
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。